Recurrent Pregnancy Loss: Causes, Controversies, and Treatment, Second EditionHoward Carp, Howard J. A. Carp CRC Press, 10 gru 2014 - 456 Recurrent pregnancy loss presents a vexing clinical problem primarily for medical professionals treating patients in reproductive medicine and in maternal-fetal medicine. However, with its numerous causes and various suggested treatment options, the problem is more multidisciplinary in nature, involving gynecology, genetics, endocrinology, immunolo |
Spis treści
The Epidemiology of Recurrent Pregnancy Loss | 1 |
Signaling between Embryo and Mother in Early Pregnancy Basis for Development of Tolerance | 17 |
Genetics of Spontaneous Abortions | 29 |
Debate Should Fetal Karyotyping Be Performed in Recurrent Pregnancy Loss? Yes | 43 |
Debate Should Fetal Karyotyping Be Performed in Recurrent Pregnancy Loss? No | 49 |
Debate Should Preimplantation Genetic Screening Be Performed in Recurrent Pregnancy Loss? Yes | 55 |
Debate Should Preimplantation Genetic Screening or Preimplantation Genetic Diagnosis Be Performed in Recurrent Pregnancy Loss? No | 59 |
Debate Screening for Chromosomal Aberrations in Recurrent Pregnancy Loss Nonspecific Testing Is Sufficient | 65 |
Opinion Can Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents? | 207 |
Uterine Anomalies and Recurrent Pregnancy Loss | 211 |
The Immunobiology of Recurrent Miscarriage | 233 |
Debate Should Immunotherapy Be Used? Lymphocyte Immunization TherapyYes | 249 |
Debate Should Immunotherapy Be Used? Intravenous ImmunoglobulinYes | 255 |
Debate Should Immunotherapy Be Used? Granulocyte Colony Stimulating FactorYes | 261 |
Debate Should Immunotherapy Be Used? No | 265 |
Autoimmunity and Recurrent Pregnancy Loss | 271 |
Debate Screening for Chromosomal Aberrations in Recurrent Pregnancy Loss Noninvasive Prenatal Testing Cytogenetics and Ultrasound Are Needed | 71 |
Does the Maternal Immune System Regulate the Embryos Response to External Toxins? | 77 |
Fetal Structural MalformationsEmbryoscopy | 87 |
Fetal Structural MalformationsUltrasound | 101 |
Endocrinology of Pregnancy Loss | 111 |
Debate Should Progesterone Supplements Be Used? Yes | 123 |
Debate Should Progesterone Supplements Be Used? No | 131 |
Opinion Progestogens in Recurrent Miscarriage | 137 |
Debate Should Human Chorionic Gonadotropin Supplementation Be Used? Yes | 143 |
Debate Should Human Chorionic Gonadotropin Supplementation Be Used? No | 149 |
Antiphospholipid SyndromePathophysiology | 155 |
Diagnosis of Antiphospholipid AntibodyAssociated Abortions | 167 |
Management of Antiphospholipid Syndrome in Pregnancy | 175 |
Defects in Coagulation Factors Leading to Recurrent Pregnancy Loss | 183 |
Debate Should Thromboprophylaxis Be Used in Hereditary Thrombophilias with Recurrent Pregnancy Loss? Yes | 197 |
Debate Should Thromboprophylaxis Be Used in Hereditary Thrombophilias with Recurrent Pregnancy Loss? No | 203 |
Infections and Recurrent Pregnancy Loss | 283 |
The Male Factor in Recurrent Pregnancy Loss and Embryo Implantation Failure | 301 |
Midtrimester Loss The Role of Cerclage and Pessaries | 313 |
Midtrimester Loss and Viability | 325 |
Obstetric Outcomes after Recurrent Miscarriage | 339 |
Coping with Repeated Pregnancy Loss Psychological Mechanisms | 351 |
Methodological Issues in EvidenceBased Evaluation of Treatment for Recurrent Miscarriage | 361 |
Investigation Protocol for Recurrent Pregnancy Loss | 375 |
A New Algorithm for Evaluation and Treatment of Recurrent Pregnancy Loss | 389 |
Third Party Reproduction in Recurrent Pregnancy Loss | 401 |
Slippery Fetus Recurrent Pregnancy Loss in Traditional Chinese Medicine | 409 |
A Patients Perspective | 417 |
Epilogue | 421 |
Back Cover | 423 |
Inne wydania - Wyświetl wszystko
Recurrent Pregnancy Loss: Causes, Controversies, and Treatment, Second Edition Howard J. A. Carp Ograniczony podgląd - 2014 |
Kluczowe wyrazy i wyrażenia
activity aneuploidy anticoagulant antigens antiphospholipid antibodies antiphospholipid syndrome aspirin assessed associated autoantibodies autoimmune bacterial vaginosis Carp cerclage cervical chorionic chromosomal abnormalities Clin clinical cohort compared controlled trial couples cytogenetic cytokines detected diagnosis dydrogesterone early pregnancy effect embryo endometrial enoxaparin evaluation Fertil Steril fetal loss fetus gene heparin hormone Hum Reprod human hysteroscopic immune immunotherapy implantation increased infants infection infertility inhibin intervention intrauterine IVIg karyotype levels live birth rate lupus maternal age meta-analysis mice NK cells normal Obstet Gynecol patients perinatal placebo placental pre-eclampsia preg pregnancy outcome preimplantation genetic preterm birth previous miscarriages progesterone prognosis protein randomized receptors recurrent miscarriage recurrent pregnancy loss recurrent spontaneous abortion Reprod Immunol reproductive role screening second trimester serum sperm spontaneous abortion subsequent testing therapy Thromb Haemostasis thrombophilia thrombosis thyroid tissue treatment trisomy trophoblast ultrasound unexplained recurrent uterine anomalies uterus vaginal vitro women with recurrent